Stay updated on MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe website's displayed software revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s release identifier changes from v3.7.2 to v3.8.0, while the study record history remains unchanged.SummaryDifference0.1%

- Check29 days agoChange DetectedA banner announces NIH's transition from the term “Artificial Intelligence” to “Super Intelligence,” and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check43 days agoChange DetectedThe site footer's displayed revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision tag v3.7.0 was added to the study history, replacing the previous v3.6.6 entry.SummaryDifference0.1%

- Check78 days agoChange DetectedThe history entry now shows Revision: v3.6.6 instead of v3.6.5, signaling a minor platform update to the page history. This change does not affect the study data or public record content.SummaryDifference0.1%

Stay in the know with updates to MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page.